I speculate that RAC have a background activity working on an oral formulation combining Zantrene and ASTX727 (note ASTX747 is a typo).
https://www.asx.com.au/asxpdf/20211101/pdf/452fm1vcm8f2j0.pdf
https://astx.com/research-developme...azuridine-astx727-hematological-malignancies/
Otsuka have their own program developing an oral combination - from the above link:
So I'm wondering if there will be an oral formulation combining decitabine, cedazuridine and Zantrene once data to help determine optimal dosage is generated.
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing & updated presentation
Ann: Race investor briefing & updated presentation, page-335
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.32 |
Change
0.055(4.37%) |
Mkt cap ! $218.5M |
Open | High | Low | Value | Volume |
$1.26 | $1.33 | $1.26 | $149.9K | 115.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.35 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 1.265 |
2 | 3000 | 1.260 |
2 | 26300 | 1.255 |
3 | 20926 | 1.250 |
1 | 1000 | 1.220 |
Price($) | Vol. | No. |
---|---|---|
1.350 | 1000 | 1 |
1.380 | 3000 | 1 |
1.390 | 8179 | 2 |
1.400 | 8530 | 3 |
1.430 | 12075 | 1 |
Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.29 |
  |
Change
0.055 ( 4.34 %) |
|||
Open | High | Low | Volume | ||
$1.26 | $1.33 | $1.26 | 12903 | ||
Last updated 15.43pm 09/05/2024 ? |
Featured News
RAC (ASX) Chart |